PHARMACOLOGICAL MANAGEMENT OF NEUROPATHIC PAIN

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S114, 2014 Special supplement with the abstract book of LATINFARMA 2013 Plenary Lecture PL 010: PHARMACOLOGICAL MANAGEMENT OF NEUROPATHIC PAIN Granizo E. Universidad Central de Ecuador. Abstract Patients with neuropathic pain are challenging to manage and evidence-based clinical recommendations for pharmacologic management are needed. In the last years the … Continue reading PHARMACOLOGICAL MANAGEMENT OF NEUROPATHIC PAIN

J Pharm Pharmacogn Res 2(Suppl. 1): S114, 2014

Special supplement with the abstract book of LATINFARMA 2013

Plenary Lecture

PL 010: PHARMACOLOGICAL MANAGEMENT OF NEUROPATHIC PAIN

Granizo E.

Universidad Central de Ecuador.
Abstract

Patients with neuropathic pain are challenging to manage and evidence-based clinical recommendations for pharmacologic management are needed. In the last years the scientific information on pharmacological treatment of neuropathic pain has increase considerably. In the present review we take into account some groups of drugs classified by their site and mechanism of action: peripheral receptors; b) peripherals nerve fibers, c) spinal pain modulators, d central descendent modulators (re-up take amines inhibitors) and opioids, tramadol. We will review the recommended first line treatment include certain antidepressants, gabapentinoids, and topic lidocaine. Opioid analgesics and tramadol are recommended as generally second-line treatments that can be considered for first –line use in select clinical circumstances. We consider useful to give some concepts of the guidelines and recommendations from “Consenso Latinoamericano para el Manejo del Dolor Neuropático”

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio